Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression
Authors:
- 3 September 2008
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 63 (6) , 997-1005
Abstract
Purpose Ovarian cancer is the leading cause of death among all gynecological malignancies in Western countries. Although therapy for ovarian cancer has been greatly improved in the past 20 years, the overall survival for patients with advanced ovarian cancer has not changed significantly. The poor survival rates in patients with advanced ovarian cancer are due both to late diagnosis and to lack of effective drugs for the majority of patients who have a relapse and develop resistance to current chemotherapy agents used for ovarian cancer. Thus, developing and discovering effective novel drugs with different molecular structures from conventional chemotherapy agents have become an urgent clinical need. Methods Ovarian cancer cells were treated with lovastatin and atorvastatin. Apoptosis in these cells and tumor formation in soft agar were determined. The molecular mechanism by which statins suppress ovarian cancer cell growth was evaluated. Results Both lovastatin and atorvastatin effectively induced apoptosis in ovarian cancer cells and suppressed anchorage-independent growth of these cells in soft agar. Further investigation of the molecular mechanism has revealed that the expression of Cdc42 and Rac1, small GTPase family members, was highly induced in the cells by these statins along with the activation of Jun N-terminal kinases (JNK). In addition, Bim, a proapoptotic protein, was significantly induced by these statins. Conclusions Our findings provide new insight into the molecular mechanism by which statins induce apoptosis in ovarian cancer cells and may lead to novel therapies for advanced ovarian cancer.Keywords
This publication has 32 references indexed in Scilit:
- Targeted therapy for epithelial ovarian cancerExpert Opinion on Therapeutic Targets, 2005
- Treatment goals in ovarian cancerInternational Journal of Gynecological Cancer, 2005
- Gemcitabine monotherapy in recurrent ovarian cancer: from the bench to the clinicInternational Journal of Gynecological Cancer, 2005
- Future options for first-line therapy of advanced ovarian cancerInternational Journal of Gynecological Cancer, 2005
- Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cellsCarcinogenesis, 2005
- Simvastatin induces proliferation inhibition and apoptosis in C6 glioma cells via c-jun N-terminal kinaseNeuroscience Letters, 2004
- The power of statins: Aggressive lipid loweringClinical Cardiology, 2003
- Proliferation, migration, and invasion of human glioma cells exposed to fractionated radiotherapy in vitroNeurosurgical Review, 2003
- Pharmacogenomics and Pharmacogenetics of Cholesterol-Lowering TherapyClinical Chemistry and Laboratory Medicine (CCLM), 2003
- The small GTPase Cdc42 initiates an apoptotic signaling pathway in Jurkat T lymphocytes.Molecular Biology of the Cell, 1997